No adverse hemodynamic interaction between sildenafil and red wine

Objective: Our objective was to investigate the hemodynamic interaction between sildenafil and red wine. Sildenafil citrate (Viagra), a phosphodiesterase type 5 inhibitor, is an effective treatment for male erectile dysfunction that potentiates nitric oxide-mediated vasodilation. Alcohol is a commonly used recreational substance with complex vascular effects, which may, in part, be mediated by nitric oxide. Thus there is potential for an adverse hemodynamic interaction. Methods: Eight healthy men received either 100 mg sildenafil, alcohol (750 mL red wine, 13.5% by volume), or the combination, in a 4-way, double placebo-controlled, randomized crossover study. Blood pressure, heart rate, and cardiac index were measured every 15 minutes up to 180 minutes. Results. Results are expressed as mean +/- SEM. Red wine increased cardiac index (by 15% +/- 8%, P =.04) and heart rate (by 27% +/- 5%, P <.0001). Mean arterial pressure initially increased by approximately 5% and then fell by a maximum of approximately 7%. Sildenafil reduced peripheral vascular resistance (by 24% +/- 8%, P =.03) and mean arterial pressure (by 7% +/- 3%, P =.03) with no effect on cardiac index or heart rate. Conclusions: There is no clinically important hemodynamic interaction between sildenafil and alcohol (red wine).